JEMPERLI
Biological
GlaxoSmithKline, LLC.
Total Payments
$9.3M
Transactions
12,792
Doctors
4,853
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $3.0M | 8,062 | 3,729 |
| 2023 | $3.1M | 3,813 | 1,988 |
| 2022 | $2.0M | 578 | 246 |
| 2021 | $1.0M | 290 | 166 |
| 2020 | $210,193 | 49 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $6.3M | 754 | 67.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.7M | 530 | 18.5% |
| Consulting Fee | $687,762 | 230 | 7.4% |
| Food and Beverage | $328,299 | 10,713 | 3.5% |
| Travel and Lodging | $280,150 | 497 | 3.0% |
| Space rental or facility fees (teaching hospital only) | $6,500 | 3 | 0.1% |
| Education | $2,689 | 65 | 0.0% |
Payments by Type
Research
$6.3M
754 transactions
General
$3.0M
12,038 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| 0000000000000000000000000000000000000000000000000000000000000000214639 | GlaxoSmithKline, LLC. | $1.2M | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214395 | GlaxoSmithKline, LLC. | $649,589 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214397 | GlaxoSmithKline, LLC. | $559,436 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214394 | GlaxoSmithKline, LLC. | $420,950 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214387 | GlaxoSmithKline, LLC. | $306,944 | 0 |
| 214395 | GlaxoSmithKline, LLC. | $261,314 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214399 | GlaxoSmithKline, LLC. | $188,980 | 0 |
| 214397 | GlaxoSmithKline, LLC. | $147,480 | 0 |
| 214394 | GlaxoSmithKline, LLC. | $143,637 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214360 | GlaxoSmithKline, LLC. | $118,398 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214438 | GlaxoSmithKline, LLC. | $113,410 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214452 | GlaxoSmithKline, LLC. | $102,623 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214448 | GlaxoSmithKline, LLC. | $97,926 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000215126 | GlaxoSmithKline, LLC. | $95,006 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214390 | GlaxoSmithKline, LLC. | $94,959 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214631 | GlaxoSmithKline, LLC. | $83,889 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000214358 | GlaxoSmithKline, LLC. | $83,439 | 0 |
| 0000000000000000000000000000000000000000000000000000000000000000219582 | GlaxoSmithKline, LLC. | $78,221 | 0 |
| 214639 | GlaxoSmithKline, LLC. | $75,530 | 0 |
| 214387 | GlaxoSmithKline, LLC. | $54,865 | 0 |
Top Doctors Receiving Payments for JEMPERLI — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD, PHD | Surgery | Basking Ridge, NJ | $33,621 | 5 |
| , ANP | Family | Albany, NY | $33,155 | 46 |
| , M.D | Gynecologic Oncology | Phoenix, AZ | $32,418 | 23 |
| , M.D | Gynecologic Oncology | New York, NY | $31,800 | 6 |
| , MD | Obstetrics & Gynecology | Dallas, TX | $27,891 | 15 |
| , M.D | Gynecologic Oncology | Jonesboro, AR | $25,655 | 20 |
| , FNP-C | Family | Phoenix, AZ | $23,391 | 33 |
| , M.D | Obstetrics & Gynecology | Galveston, TX | $21,223 | 28 |
| , MD | Gynecologic Oncology | Houston, TX | $21,141 | 16 |
| , MD | Specialist | Everett, WA | $20,697 | 23 |
| , FNP-BC | Family | Tyler, TX | $19,841 | 33 |
| , MD | Gynecologic Oncology | New Orleans, LA | $19,701 | 13 |
| , MD | Obstetrics & Gynecology | Tyler, TX | $19,419 | 18 |
| , M.D | Gynecologic Oncology | Chicago, IL | $18,790 | 7 |
| , M.D | Obstetrics & Gynecology | Gilbert, AZ | $18,487 | 6 |
| , NP | Nurse Practitioner | Chattanooga, TN | $18,215 | 38 |
| , MD, MPH | Obstetrics & Gynecology | New York, NY | $17,678 | 7 |
| , MD | Obstetrics & Gynecology | Huntington, WV | $16,546 | 11 |
| , M.D | Gynecologic Oncology | Delray Beach, FL | $15,307 | 14 |
| , MD | Internal Medicine | Los Angeles, CA | $14,241 | 9 |
| , M.D | Medical Oncology | Boston, MA | $14,000 | 1 |
| , M.D | Internal Medicine | Ridge, NY | $12,287 | 8 |
| , M.D | Gynecologic Oncology | Cincinnati, OH | $11,467 | 5 |
| , M.D | Hematology & Oncology | Beverly, MA | $11,213 | 1 |
| , MD | Gynecologic Oncology | Orange, CA | $11,184 | 9 |
Ad
Manufacturing Companies
- GlaxoSmithKline, LLC. $9.3M
Product Information
- Type Biological
- Total Payments $9.3M
- Total Doctors 4,853
- Transactions 12,792
About JEMPERLI
JEMPERLI is a biological associated with $9.3M in payments to 4,853 healthcare providers, recorded across 12,792 transactions in the CMS Open Payments database. The primary manufacturer is GlaxoSmithKline, LLC..
Payment data is available from 2020 to 2024. In 2024, $3.0M was paid across 8,062 transactions to 3,729 doctors.
The most common payment nature for JEMPERLI is "Unspecified" ($6.3M, 67.5% of total).
JEMPERLI is associated with 20 research studies, including "0000000000000000000000000000000000000000000000000000000000000000214639" ($1.2M).